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Abstract
With vast improvements in healthcare in recent decades, people are living longer but often with higher rates of
morbidity and chronic illnesses. This has resulted in a higher proportion of the population who may benefit from
early end-of-life ‘conversation and planning’, but also gives healthcare professionals more time during which these
discussions are relevant, as people live longer with their chronic diseases. A survey conducted by Lifshitz et al (Isr J
Health Policy Res 5:6, 2016) sought to assess physician awareness and willingness to discuss designating a proxy
decision-maker with patients, in order to aid end-of-life care in the event that the patient is rendered unable to
make or communicate these decisions later in life.
Their article suggests that proxy decision-maker designation is only one aspect of end-of-life care; a challenging
area littered with ethical and moral dilemmas. Without early, open and frank discussions with patients regarding
their wishes at the end of life, proxy decision-makers may be in no better position than physicians or a court
appointed proxy to make decisions in the patients’ best interests/benefits. This commentary also touches upon the
use of health and care passports being developed or in early phases in the United Kingdom, and whether these
may be utilised in the field of palliative care in Israel.
Background
Palliative care is a relatively new medical specialty, ex-
periencing a period of rapid growth and development
following the opening of St. Christopher’s Hospice in
London, the first of its kind, in 1967 by Cicely Saunders
(http://www.stchristophers.org.uk/about/history/pioneer-
ingdays). The principles of palliative care centre on hol-
istic care of the person who is usually in the final phase
of life, including addressing psychological and spiritual
needs, as well as enabling the patient to live as actively
as they wish until death [1]. It is important to note that,
where formal palliative care services exist it is not con-
fined to patients who are deemed end-of-life, although
that is primary focus of this commentary. In Israel, pal-
liative care is yet to establish itself as a board-certified
specialty.
It is not just the clinical management of patients
approaching towards end-of-life that is challenging.
Decision making regarding place of care, hospitalization,
artificial feeding, intravenous fluid replacement,
intubation, preferred place of dying, and even cardiopul-
monary resuscitation can be extremely sensitive issues.
One should endeavour to involve patients in making all
of these decisions, wherever possible. But what should
be done when patients are unable to communicate these
wishes? Consideration of these issues often starts too
late on in the patient journey, and quite often the patient
has already reached a stage where they can not commu-
nicate their wishes.
Key findings and recommendations from Lifshitz and
colleagues
One option to aid healthcare professions in addressing
end-of-life issues is to facilitate the designation of proxy-
decision makers (PDM), often a relative or close friend
of the patient. The survey conducted by Gideon Lifshitz
[2] and colleagues published in this issue sought to as-
sess how willing primary care physicians were to explore
this option with their patients, at what point they
thought it appropriate, and the perceived issues in doing
so. Some of their results are quite interesting.
When asked at what point in a patient’s journey the
primary care physicians felt it appropriate to discuss the
appointment of a PDM, 91 % felt this was relevant when
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patients were suffering from severe chronic conditions,
such as cancer or heart failure. However, only 24 % felt
this was an appropriate discussion to have with ‘all’ eld-
erly patients. This seems a somewhat surprising result.
The World Health Report, 2003 [3] estimated that de-
mentia contributed 11 · 2 % of years lived with disability
in people aged 60 years and older; more than stroke
(9 · 5 %), musculoskeletal disorders (8 · 9 %), cardiovas-
cular disease (5 · 0 %), and all forms of cancer (2 · 4 %).
These figures, combined with the knowledge that the
disease course of dementia itself will eventually render
a person unable to make decisions with capacity, sug-
gest that dementia may be one of the most common
scenarios in which a person may benefit from having
designated a PDM. In the cases of those with living
with cancer or heart failure, the point of diagnosis can
act as a prompt to discuss the appointment of a PDM.
In those living with dementia, the point at which diag-
nosis is made may not give enough time to discuss the
important end-of-life issues, due to a lack of capacity.
Having this discussion with all elderly patients may be
a way to address this issue, prior to or early on at the
time of diagnosis of chronic cognitive impairment.
Addressing the challenge of shifts in patient preferences
One of the main perceived impediments to discussing
the appointment of a PDM was that primary care physi-
cians felt that patients may change their minds in later
life. This could be true regardless of any planning under-
taken to prepare for end of life issues. Advance state-
ments, or a person acting as a PDM, would both need
regular review and updating regarding patient prefer-
ences. In Israel, there is a distinction made between a
court appointed proxy, known as a legal guardian, and
patient designated proxies, usually a friend or relative.
However, when a proxy is appointed, this does not neg-
ate the need to discuss these issues with patients early on.
Although the designated person may be a friend or rela-
tive, this does not suggest they would necessarily know
what the patient would want in terms of feeding, care
provision, or place of death. Without facilitation or en-
couragement of those discussions, proxy-decision makers
may be left in a stressful and uncomfortable position,
where they feel the responsibility of making important
end of life decisions for someone, despite having never
been able to talk with the patient about these specific
topics. We propose why should not these early discussions
about ‘end of life plans’ be called ‘rest of life plans’ instead?
Would it help in making these discussions somewhat eas-
ier and more acceptable in society?
Economic considerations
Controversially, one of the perceived benefits of early
discussion of a PDM that emerged in this survey was
around the cost of service provision at the end of life.
Lifshitz et al. commented that currently, if no advanced
planning has taken place, the medical profession is more
likely to provide all treatments available, rather than pal-
liation early on, despite a sense of futility in certain
cases. This may well be the case, but quite often it is the
physician who is able to identify the patient who is en-
tering the final phases of life, and when physician led
discussions do take place regarding withdrawal of treat-
ment and palliation, this may meet resistance from the
family or friends of the dying patient,. There is often a
sense of turmoil, uncertainty, and occasionally guilt em-
anating from the family and friends of such patients.
Family and friends would generally want to do what they
think the patient would have wanted, but when unable
to ask their loved one about their preferences, they feel
better by trying to do more. The designation of a PDM
alone may not reduce the unwanted, costly, and some-
times undignified, medical interventions. Discussions with
the patients early on, however, may help in doing so.
Due to their sensitive nature, such decisions will often
require more than one or two meetings and there will
still remain a need to review these periodically. In our
experience, these meetings are likely to be much longer
than standard outpatient clinic appointments and are
probably best carried out in an inter-disciplinary envir-
onment incorporating family members, carers, nurses,
therapists and with agreement from patients’ usual fam-
ily physician.
Physician reimbursement schemes may also need to
reflect what best practice is. In the UK general practice,
there is an incentive for the general practitioners to
make a summary advance care plan [4] for the top two
percent of patients at risk of hospital admission These
patients are generally older people with multi-morbidity.
This patient-held record summarizes the patients’ med-
ical details and requires the physician to hold regular
discussions with the patient regarding advanced care
planning. This includes their preferences regarding place
and type of care or interventions they may want or not
want when their health deteriorates. There is an expect-
ation that these will be updated periodically.
In a commentary by Kinzbrunner and Kinzbrunner,
the emerging field of spiritual care in Israel recognises
the importance of a wide range of healthcare profes-
sionals, to include nurses, social workers and rabbis, in
providing spiritual care to those with oncological or pal-
liative diagnoses [5]. It may be appropriate to involve
this same group of care providers should a similar ad-
vance care planning tool be adopted in Israel. Chaplains
of all faiths are available to patients in UK hospitals;
however they tend not to be involved in healthcare or
end of life decisions, with an extremely limited role in
the multidisciplinary team at present.
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In the UK, there is an on-going debate as to which
care provider is best placed to have these discussions –
primary or secondary care. Essentially, both levels of
care should play important roles in advanced planning,
and all contact with healthcare providers should be seen
as an opportunity to have such discussions when appro-
priate and able.
Recent UK developments
In the UK, people are able to appoint a Lasting Power of
Attorney for health and welfare, providing legal docu-
mentation of designated proxy decision makers. Once
appointed, this directive remains in place for the dur-
ation of the patients’ lifetime. It is now recognised that
more formal documentation of patients and relatives
wishes would be an invaluable addition to this.
There are multiple types of healthcare ‘passports’ at
varying stages of development, and in certain specialties,
such as obstetrics and paediatrics, these documents are
already in widespread use. More recently, we have devel-
oped a comprehensive document; a ‘©Rest of life care
passport ‘or ‘©Frailty Passport’ [Rest of Life Care Passport,
Amit Arora, Unpublished data, forthcoming] to summarize
these discussions and ease the patient journey through vari-
ous providers and transitions of care. This aims to reduce
the need for repeated and often ‘piece-meal’ discussions by
various professionals, helps with seamless journey through
transitions of care between primary, secondary, social care
interfaces and between different geographical locations. It
also has been noted to be useful in reducing length of stay
in those patients who get admitted to hospitals repeatedly
and often get ‘stranded’. It includes a summary of medical
conditions, a list of the key care providers, an emergency
care plan, patients’ wishes, and agreements around medical
and social care plans, next of kin details and details of
PDMs as nominated by the patients. It also aims to cover
certain important end of life issues (Box 1) that patients
may feel strongly about, giving them the opportunity to
make their wishes known in advance. There is a need to
share these and keep them reviewed on a regular basis. It is
hoped that for such conversations to be effective, they
should start to take place with in last couple of years of life
or in very early stages of dementia onset.
A commentary by Cassileth in 2012 [6] describes the
progress achieved by the Middle East Cancer Consortium
set up in Israel to improve end of life care. One route they
have taken has been to hold annual meetings to help edu-
cate and promote palliative care throughout the Middle
East. There will be differing ideas across countries regard-
ing the importance of all aspects of end of life care, in-
cluding emotional and spiritual wellbeing and religious
beliefs may also play an important part in this. An ‘A Rest
of Life passport’ may be appropriate to adopt to provide a
framework of areas to consider for a patient who is
approaching the end stages of life. This may help to pro-
vide some level of standardisation and yet remain flexible
enough to be transferable to most population groups.
Box 1 Some suggested areas to be covered in a ‘Frailty
Passport’®
Conclusions
In this relatively new and growing specialty, there are
sensitive and difficult issues to broach, both with pa-
tients and their loved ones. Early, open and honest dis-
cussions to encourage consideration of these issues are a
vital first step in planning for the palliative phase of life.
Communication skills development and education early
in medical training will help. However, this will also re-
quire societal education to reduce stigma and increase
awareness around difficult conversations around end of
life issues.
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Nasogastric tube feeding or PEG feeding to prolong life
Intravenous or subcutaneous fluids to prolong life
Admission to Intensive care/mechanical ventilation/dialysis/surgery etc.
Advance statements about wishes and preferences
Religious preferences
Preferred place of death
Proxy decision maker details and next of kin details
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